Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph L Pater

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 4, 2004
Treatment of locally advanced breast cancerJoseph L Pater
Canadian Bulletin of Medical History = Bulletin Canadien D'Histoire De La Medecine|October 27, 2018
Mrs. Robinson's Revenge: Pete Seeger, Earl Robinson, and the Medicare Protest SongJacalyn Duffin, Joseph L Pater
Canadian Bulletin of Medical History = Bulletin Canadien D'Histoire De La Medecine|October 3, 2018
Mrs. Robinson's Revenge: Pete Seeger, Earl Robinson, and the Medicare Protest SongJacalyn Duffin, Joseph L Pater
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003
Optimal chemotherapy for women with breast cancer: the plot thickensJoseph L Pater, Kathleen I Pritchard
Journal of the National Cancer Institute|December 18, 2003
Ovarian ablation as adjuvant therapy for premenopausal women with breast cancer--another step forwardJoseph L Pater, Wendy R Parulekar
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2008
Stopping trials for benefit can (sometimes) benefit patientsJoseph L Pater, Paul Goss, Ralph Meyer
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2003
Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer modelsTheodora Voskoglou-Nomikos, Joseph L Pater, Lesley Seymour
Breast Cancer Research and Treatment|June 30, 2005
The importance of temporal effects in evaluating the prognostic impact of joint ERPR expression in premenopausal women with node-positive breast cancerYandong Ouyang, Dongguang Li, Joseph L Pater, et al.
Cancer|March 14, 2007
Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant tamoxifenChristopher M Booth, Joseph L Pater, Paul E Goss
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Enrollment of older patients in cancer treatment trials in Canada: why is age a barrier?Karen W L Yee, Joseph L Pater, Lam Pho, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 4, 2004
Treatment of locally advanced breast cancerJoseph L Pater
Canadian Bulletin of Medical History = Bulletin Canadien D'Histoire De La Medecine|October 27, 2018
Mrs. Robinson's Revenge: Pete Seeger, Earl Robinson, and the Medicare Protest SongJacalyn Duffin, Joseph L Pater
Canadian Bulletin of Medical History = Bulletin Canadien D'Histoire De La Medecine|October 3, 2018
Mrs. Robinson's Revenge: Pete Seeger, Earl Robinson, and the Medicare Protest SongJacalyn Duffin, Joseph L Pater
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003
Optimal chemotherapy for women with breast cancer: the plot thickensJoseph L Pater, Kathleen I Pritchard
Journal of the National Cancer Institute|December 18, 2003
Ovarian ablation as adjuvant therapy for premenopausal women with breast cancer--another step forwardJoseph L Pater, Wendy R Parulekar
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2008
Stopping trials for benefit can (sometimes) benefit patientsJoseph L Pater, Paul Goss, Ralph Meyer
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2003
Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer modelsTheodora Voskoglou-Nomikos, Joseph L Pater, Lesley Seymour
Breast Cancer Research and Treatment|June 30, 2005
The importance of temporal effects in evaluating the prognostic impact of joint ERPR expression in premenopausal women with node-positive breast cancerYandong Ouyang, Dongguang Li, Joseph L Pater, et al.
Cancer|March 14, 2007
Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant tamoxifenChristopher M Booth, Joseph L Pater, Paul E Goss
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Enrollment of older patients in cancer treatment trials in Canada: why is age a barrier?Karen W L Yee, Joseph L Pater, Lam Pho, et al.
Pageof 3